120 related articles for article (PubMed ID: 17483061)
1. Bacterial bloodstream infection in neutropenic adult patients after myeloablative cord blood transplantation: experience of a single institution in Japan.
Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kobayashi T; Sato A; Takasugi K; Iseki T; Tojo A; Asano S
Int J Hematol; 2007 Apr; 85(3):238-41. PubMed ID: 17483061
[TBL] [Abstract][Full Text] [Related]
2. The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study.
Ge J; Yang T; Zhang L; Zhang X; Zhu X; Tang B; Wan X; Tong J; Song K; Yao W; Sun G; Sun Z; Liu H
BMC Infect Dis; 2018 Dec; 18(1):654. PubMed ID: 30545330
[TBL] [Abstract][Full Text] [Related]
3. Pre-engraftment bloodstream infections in acute leukemia patients undergoing unrelated cord blood transplantation following intensified myeloablative conditioning without ATG.
Zheng C; Tang B; Zhu X; Zhang X; Zhang L; Geng L; Liu H; Sun Z
Ann Hematol; 2017 Jan; 96(1):115-124. PubMed ID: 27771742
[TBL] [Abstract][Full Text] [Related]
4. Bloodstream infections in adult patients undergoing cord blood transplantation from unrelated donors after myeloablative conditioning regimen.
Sanz J; Cano I; González-Barberá EM; Arango M; Reyes J; Montesinos P; Lorenzo I; Jarque I; Martínez J; López F; Arilla MJ; Lancharro A; Moscardó F; López-Hontangas JL; Salavert M; Sanz MA; Sanz GF
Biol Blood Marrow Transplant; 2015 Apr; 21(4):755-60. PubMed ID: 25585274
[TBL] [Abstract][Full Text] [Related]
5. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
6. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients.
Narimatsu H; Matsumura T; Kami M; Miyakoshi S; Kusumi E; Takagi S; Miura Y; Kato D; Inokuchi C; Myojo T; Kishi Y; Murashige N; Yuji K; Masuoka K; Yoneyama A; Wake A; Morinaga S; Kanda Y; Taniguchi S
Biol Blood Marrow Transplant; 2005 Jun; 11(6):429-36. PubMed ID: 15931631
[TBL] [Abstract][Full Text] [Related]
7. Bloodstream infection in heart transplant recipients: 12-year experience at a university hospital in Taiwan.
Hsu RB; Chang CI; Fang CT; Chang SC; Wang SS; Chu SH
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1362-7. PubMed ID: 21459606
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: A single-center cohort study.
Gjaerde LI; Moser C; Sengeløv H
Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28561378
[TBL] [Abstract][Full Text] [Related]
9. Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis.
Choeyprasert W; Hongeng S; Anurathapan U; Pakakasama S
Int J Hematol; 2017 Feb; 105(2):213-220. PubMed ID: 27771837
[TBL] [Abstract][Full Text] [Related]
10. Early infections in adult patients undergoing unrelated donor cord blood transplantation.
Saavedra S; Sanz GF; Jarque I; Moscardó F; Jiménez C; Lorenzo I; Martín G; Martínez J; De La Rubia J; Andreu R; Mollá S; Llopis I; Fernández MJ; Salavert M; Acosta B; Gobernado M; Sanz MA
Bone Marrow Transplant; 2002 Dec; 30(12):937-43. PubMed ID: 12476288
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.
Kikuchi M; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
Transpl Infect Dis; 2015 Feb; 17(1):56-65. PubMed ID: 25580541
[TBL] [Abstract][Full Text] [Related]
12. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
Busca A; Cavecchia I; Locatelli F; D'Ardia S; De Rosa FG; Marmont F; Ciccone G; Baldi I; Serra R; Gaido E; Falda M
Transpl Infect Dis; 2012 Feb; 14(1):40-8. PubMed ID: 21599817
[TBL] [Abstract][Full Text] [Related]
13. G-CSF-primed haplo-identical HSCT with intensive immunosuppressive and myelosuppressive treatments does not increase the risk of pre-engraftment bloodstream infection: a multicenter case-control study.
Ren J; Lin Q; Chen W; Lin C; Zhang Y; Chen C; Chen S; Yuan X; Chen P; Luo X; Lin Y; Shen L; Guo M; Chen Q; Xiao M; Chen Y; Wu X; Zeng Y; Chen Z; Ma X; Hu J; Yang T
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):865-876. PubMed ID: 30685808
[TBL] [Abstract][Full Text] [Related]
14. Retrospective evaluation of the area over the neutrophil curve index to predict early infection in hematopoietic stem cell transplantation recipients.
Kimura S; Oshima K; Sato K; Sato M; Terasako K; Nakasone H; Kikuchi M; Okuda S; Kako S; Yamazaki R; Tanaka Y; Tanihara A; Nishida J; Kanda Y
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1355-61. PubMed ID: 20457267
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of bacterial bloodstream infections and association between neutropenia and 30-day mortality among oncology inpatients at a university hospital in Saudi Arabia.
Binkhamis K; Aldakhil I; Alhawas A; Alsaleh A; Albaroudi A; Almuhanna B; Makkawi M; Alzahrani M
Ann Saudi Med; 2023; 43(3):172-178. PubMed ID: 37270682
[TBL] [Abstract][Full Text] [Related]
16. Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study.
Kern WV; Roth JA; Bertz H; Götting T; Dettenkofer M; Widmer AF; Theilacker C;
Transpl Infect Dis; 2019 Dec; 21(6):e13186. PubMed ID: 31574202
[TBL] [Abstract][Full Text] [Related]
17. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
Gudiol C; Bodro M; Simonetti A; Tubau F; González-Barca E; Cisnal M; Domingo-Domenech E; Jiménez L; Carratalà J
Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
[TBL] [Abstract][Full Text] [Related]
18. Cord Blood Transplantation for Multiple Myeloma: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Kawamura K; Takamatsu H; Ikeda T; Komatsu T; Aotsuka N; Amano I; Yamamoto G; Watanabe K; Ohno Y; Matsue K; Kouzai Y; Tsukada N; Ishiyama K; Anzai N; Kato K; Suzuki R; Sunami K; Kanda Y
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1291-8. PubMed ID: 25708214
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Etiology, Risk Factors, and Outcomes of Bloodstream Infection after a Second Hematopoietic Stem Cell Transplantation.
Ohta T; Ueno T; Uehara Y; Yokoyama T; Nakazawa M; Sato Y; Uchida Y; Ohno Y; Sugio Y
Intern Med; 2023 Nov; 62(22):3305-3316. PubMed ID: 37032079
[TBL] [Abstract][Full Text] [Related]
20. Bloodstream infection after stem cell transplantation in children with idiopathic aplastic anemia.
Kobayashi R; Yabe H; Kikuchi A; Kudo K; Yoshida N; Watanabe K; Muramatsu H; Takahashi Y; Inoue M; Koh K; Inagaki J; Okamoto Y; Sakamaki H; Kawa K; Kato K; Suzuki R; Kojima S
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1145-9. PubMed ID: 24727336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
